Αποτελέσματα Αναζήτησης
TYSABRI Outreach: Unified Commitment to Health. TOUCH On-Line is a web-based tool designed to assist TOUCH Prescribing Program participants in fulfilling their TOUCH Prescribing Program Requirements.
- Touch On-Line
TOUCH Prescribing Program TYSABRI Outreach: Unified...
- How to Enroll
How do I enroll in the TOUCH Prescribing Program?...
- Touch On-Line
TOUCH On-Line is a web-based tool designed to: Provide real-time access to data for patients taking TYSABRI. Maintain compliance with the TOUCH Prescribing Program. Reduce administrative burden/paperwork for prescribers and infusion sites. Streamline communication to/from prescribers and infusion sites.
TYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML).
Understanding PML for Gastroenterologists. To learn more about enrolling in the TOUCH Prescribing Program, contact a TYSABRI Support Specialist at Biogen, call toll free: 1-800-456-2255 Monday-Friday, 8:30 AM to 8:00 PM (ET).
• TOUCH On-Line is a web-based tool designed to: – Provide real-time access to TYSABRI patient data – Maintain compliance with the TOUCH Prescribing Program
27 Οκτ 2023 · TYSABRI (natalizumab) injection, for intravenous ... Table of Contents. BOXED WARNING (What is this?) WARNING: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY. TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability.
4 Αυγ 2023 · The Tysabri TOUCH Prescribing Program is a restricted program developed by the manufacturer of Tysabri and the US Food and Drug Administration (FDA) intended to educate healthcare professionals and patients on the risks of using Tysabri, including progressive multifocal leukoencephalopathy (PML).
